Ann: IHL-42X positive phase 2 clinical trial results, page-117

In regards to price manipulation, let's not forget that in the last 12 months that IHL has grown significantly in terms of it's networks and partnerships,

We have Roth, the PR firm, various universities and not to mention all the networking Joel is doing over there in the US of A

Now, I wouldn't be one to ever accuse the directors of a leaky ship, but let's take into consideration that there's a lot more people "in" the company now.

Here's an interesting article about a peculiar method that companies exploit leaky ships.

https://www.anu.edu.au/news/all-news/study-exposes-insider-trading-on-australian-stock-market

I really hope it's not happening here, but we all seem a bit gobsmacked.

Or it could just be short termers leaving who bought on the hype. Who knows?

GLTA